Discovery offers hope for reducing immune-related heart risks in cancer patients Post author:admin Post published: February 20, 2026 Post category:uncategorized For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. You Might Also Like Stroke remains a leading cause of death globally, with increased risk linked to lifestyle factors October 4, 2024 Sweetened tea doesn’t offer the same health benefits August 7, 2025 AI model enhances detection of antibiotic resistance in deadly bacteria April 7, 2025
Stroke remains a leading cause of death globally, with increased risk linked to lifestyle factors October 4, 2024